Search research articles
Contact Us
Filters
Showing results (191-200 of 197) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 197 results.
Cancer Cell
|
July 18, 2006
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer
Bin-Bing S Zhou, Michael Peyton, Biao He, et al.
Cell Reports
|
April 7, 2015
NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer
Collin M Blakely, Evangelos Pazarentzos, Victor Olivas, et al.
The Lancet. Respiratory Medicine
|
June 27, 2025
Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial
David R Spigel, Virginie Westeel, Ian C Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study
Collin M Blakely, Anatoly Urisman, Matthew A Gubens, et al.
Biorxiv : the Preprint Server for Biology
|
June 8, 2021
SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator
Lisiena Hysenaj, Samantha Little, Kayla Kulhanek, et al.
Lancet (London, England)
|
January 31, 2012
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
Johannes R Kratz, Jianxing He, Stephen K Van Den Eeden, et al.
Stem Cell Reports
|
February 24, 2023
SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants
Lisiena Hysenaj, Samantha Little, Kayla Kulhanek, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 197) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 197 results.
Cancer Cell
|
July 18, 2006
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer
Bin-Bing S Zhou, Michael Peyton, Biao He, et al.
Cell Reports
|
April 7, 2015
NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer
Collin M Blakely, Evangelos Pazarentzos, Victor Olivas, et al.
The Lancet. Respiratory Medicine
|
June 27, 2025
Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial
David R Spigel, Virginie Westeel, Ian C Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study
Collin M Blakely, Anatoly Urisman, Matthew A Gubens, et al.
Biorxiv : the Preprint Server for Biology
|
June 8, 2021
SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator
Lisiena Hysenaj, Samantha Little, Kayla Kulhanek, et al.
Lancet (London, England)
|
January 31, 2012
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
Johannes R Kratz, Jianxing He, Stephen K Van Den Eeden, et al.
Stem Cell Reports
|
February 24, 2023
SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants
Lisiena Hysenaj, Samantha Little, Kayla Kulhanek, et al.
Page
of 20